Font Size: a A A
Keyword [secondary prevention]
Result: 1 - 20 | Page: 1 of 8
1. Current Investigation Of Secondary Prevention Among Ischemic Cerebrovascular Diseases In Zhangqiu
2. The Regulation Study Of The Dengzhan Shengmai Capsule For Secondary Prevention Of Ischemic Stroke Patients With MMPs,TIMPs And HDL-C
3. Wingspan Stenting For Symptomatic Intracranial Atherosclerotic Artery Stenosis
4. Taicang, China Region And Western Europe, The Flemish Of Hypertension Epidemiological Studies
5. The Initial Screening Of Heart Failure Related To Serum Markers And Related Research, And Ventricular Remodeling
6. Statins In High-risk Arterial Atherosclerotic Vascular Disease In The Application Status Survey
7. Study On The Implementation Effects And The Influencing Factors Of Neural Tube Defects Intervention Measures
8. Study On The Compliance Of Secondary Prevention Of Ischemic Stroke And Its Influencing Factors
9. A Prospective Randomized Control Double-blinded Phase Ⅲ Clinical Study Of Cilostazol In Prevention Of Recurrence Of Cerebral Infarction
10. Prevalence And Management Of Risk Factors In Patients With Revascularized Coronary Heart Disease
11. Clinical Rearch Of The Secondary Prevention Effect On Coronary Heart Disease Of The Coronary Heart Disease (CHD) Capsules Worked Out By Prof. Deng
12. Investigation And Follow-up Of The Patients With ICD Indications
13. Preliminary Study On The Secondary Prevention (6 Months) For Ischemic Stroke By Erigeron Shengmai Capsule
14. Study On The Use Of Aspirin Combined With Blood-activiating And Stasis-dissolving Chinese Patent Medicine For Patients With Stable Angina Pectoris
15. Investigation And Follow-up Of The Patients With ICD Indications
16. A Pilot Study With Combination Of Berberine And Atorvastatin For Secondary Prevention With Acute Ischemic Stroke
17. Clinical Research About Expression Of CK19 And EpCAM In Gastric Cancer Using Tissue Chip Technology
18. Hypertension Awareness, Treatment, And Control Status Among Ischemic Stroke Survivors In Community
19. Cardiovascular Risk Factors Management Survey In Patients Of Hospitalization With Coronary Heart Disease
20. The Variation Of The Cholesterol Metabolism Markers During Antilipemic Therapy In Patients With Coronary Heart Disease
  <<First  <Prev  Next>  Last>>  Jump to